SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
36 Sold my GILD this week (25.25 on Wed) Took the money from the run up from 17.25phbolton-9/1/1996
35 Following the Vancouver AIDS Conference, the market has taken the good news of John Metcalf-8/30/1996
34 One look at the current price of BioChem Pharma ($35) who is currently selling Mark Nelson-8/21/1996
33 I am very Bullish on Gilead. From what I have read in the medical literature vpaul001-8/18/1996
32 Furman Selz: Latest Ratings: CNTO GILD NXCO Dow Jones News Service ~ Augphbolton-8/17/1996
31 Halting one of its three Protovir trials due to "lack of efficiency evidephbolton-8/15/1996
30 All: Seems we have a bit of positive price momentum; simple rebound off the recdeveloper-8/15/1996
29 I think you may be confused about Gilead. They do not sell Scopalomine and havphbolton-8/13/1996
28 What is the percentage of Scopalomine to profits? This very popular drug was ofSkywatcher-8/12/1996
27 The protease inhibitors seem to stop progress of HIV but do not enhance T cell phbolton-8/11/1996
26 This announcement was excellent news, but it didn't do much for the stock (Paul Getman-8/10/1996
25 Gilead announces deal with Pharmacia-Upjohn to market Vistide outside of US. Tphbolton-8/8/1996
24 The AIDS drug just approved is called Vistide, and it is useful to treat a viraDoug Meetmer-7/30/1996
23 John, Thanks for a swift and reasoned response. You seem to have muck expertisdeveloper-7/24/1996
22 At this level ($18-19) Gilead is a good deal. There's more than $10 a sharJohn Metcalf-7/24/1996
21 John, Thanks. Any thoughts on purchasing GILD at this level. Was there any mendeveloper-7/24/1996
20 Paul, Gilead is a research-based company with some great science, cash to complJohn Metcalf-7/21/1996
19 Chris: Well, I also hope it rises from here since I just bought some more. Orphbolton-7/21/1996
18 John, I have just started following and reading about Gilead and I am wonderindeveloper-7/21/1996
17 I'd love to get some more at this price but I took a drubbing and will haveSkywatcher-7/16/1996
16 GILD is now at about $17, they have about $10/share in the bank, about $10/sharphbolton-7/15/1996
15 bob: thanks for the complete news on Gilead. It is very heartening for those ofSkywatcher-6/28/1996
14 An announcement from Gilead was on this afternoon's newswire. This is exceBob Goldman-6/27/1996
13 Yes, UCSF medical center. According to my sources he was heading up the whole tSkywatcher-6/25/1996
12 Chris: I own a pretty big position in Sequus (bought long ago at much lowJohn B. Anderson-6/23/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News